TASIGNA 150MG CAPSULE 4'S

TASIGNA 150MG CAPSULE 4'S may cause liver function abnormalities, which may indicate liver damage. It is important to have regular blood tests to monitor your liver function while taking this medicine. If you experience symptoms of liver damage, such as jaundice or abdominal pain, you should contact your doctor immediately.

TASIGNA 150MG CAPSULE 4'S differs from other medications like Imatinib in its selectivity and potency. It is more selective for the BCR-ABL protein that drives cancer cell growth and more potent in inhibiting its activity. It is also effective in patients resistant to Imatinib.

The potential long-term effects of TASIGNA 150MG CAPSULE 4'S on the body include cardiovascular events, such as hypertension, arrhythmias, and heart failure, as well as liver dysfunction, pancreatic enzyme elevation, and fluid retention. These side effects are generally rare, but they can occur in some patients.

The effects of TASIGNA 150MG CAPSULE 4'S are monitored through regular blood tests, electrocardiograms (ECG), and imaging studies. Blood tests assess liver and kidney function, blood counts, and electrolyte levels. ECG detects changes in heart rhythm or function. Imaging studies like echocardiograms and chest X-rays evaluate the heart and lungs for damage or fluid accumulation.

TASIGNA 150MG CAPSULE 4'S should not be taken by pregnant or breastfeeding women, or by people with certain medical conditions such as severe liver or kidney disease, a history of pancreatitis, or a prolonged QT interval.

TASIGNA 150MG CAPSULE 4'S may interact with other medications. It is crucial to inform your doctor about all prescription, over-the-counter, and herbal medicines you are currently taking to avoid potential interactions.

Follow your doctor's instructions regarding the dose; a lower dose may be prescribed based on your condition. It is suitable for people aged 65 and over at the same dose as adults. Report irregular heartbeats or signs of heart conditions immediately. Inform your doctor about kidney problems; they will monitor kidney function. Growth may be monitored in children and adolescents. Report a history of heart failure or hepatitis infection. Discuss effective contraception options with your healthcare provider.

TASIGNA 150MG CAPSULE 4'S contains the active molecule NILOTINIB.

TASIGNA 150MG CAPSULE 4'S is primarily used to treat Chronic Myeloid Leukemia (CML), a type of blood cancer.

TASIGNA 150MG CAPSULE 4'S works by targeting specific proteins that contribute to the growth of cancer cells, helping to slow or stop their progression.